Showing results (1-10 of 250) with videos related to
Sort By:
Pageof 25
Seminars in Thrombosis and Hemostasis|May 26, 2007
Hemostatic dysfunction in paraproteinemias and amyloidosisMaurizio Zangari, Francesca Elice, Louis Fink, et al.Expert Review of Anticancer Therapy|March 7, 2007
Thrombosis in multiple myelomaMaurizio Zangari, Francesca Elice, Louis Fink, et al.British Journal of Haematology|August 3, 2006
Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolismFrancesca Elice, Louis Fink, Guido Tricot, et al.Expert Opinion on Investigational Drugs|November 1, 2005
Immunomodulatory drugs in multiple myelomaMaurizio Zangari, Francesca Elice, Guido TricotClinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimensMaurizio Zangari, Louis Fink, Fenghuang Zhan, et al.Seminars in Thrombosis and Hemostasis|October 30, 2012
Mechanisms of thrombosis in paraproteinemias: the effects of immunomodulatory drugsMaurizio Zangari, Tamara Berno, Fenghuang Zhan, et al.Seminars in Thrombosis and Hemostasis|July 31, 2003
The blood coagulation mechanism in multiple myelomaMaurizio Zangari, Fariba Saghafifar, Paulette Mehta, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 25, 2007
Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patientsMaurizio Zangari, Bart Barlogie, Federica Cavallo, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 4, 2011
Activated protein C resistance as measured by residual factor V after Russell's viper venom and activated protein C treatment analyzed as a continuous variable in multiple myeloma and normal controlsMaurizio Zangari, Tamara Berno, Fenghuang Zhan, et al.Current Opinion in Supportive and Palliative Care|July 27, 2010
Bone and paraproteinemiasMaurizio Zangari, Fenghuang Zhan, Guido TricotPageof 25